Absolute bioavailability

AbsBioOur capabilities in intravenous (IV) formulation development, real-time manufacturing and clinical testing allow us to generate IV pharmacokinetic and absolute bioavailability data, supporting your development programs and regulatory submissions.

We have a wealth of experience in performing absolute bioavailability assessments using a variety of approaches, including with a radiolabeled product for ivMicrotracer™ studies, or unlabeled drug product for IV/oral crossover studies.